FDA OKs Pfizer COVID-19 Boosters for 65 and Older, High-Risk Americans
The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to older Americans and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of the extra shots.
















